Legal updates and opinions
News / News
Compensation for employees who experience injuries, illness or death as a result of the Covid-19 vaccine
Compensation for Occupational Injuries and Diseases Act 130 of 1993
by Jacques van Wyk, Director and Andre van Heerden, Senior Associate
On 22 October 2021, a notice was published in the Government Gazette in terms of section 6A(b) of the Compensation for Occupational Injuries and Diseases Act 130 of 1993 (“COIDA“). The notice relates to the compensation for side effects to the Covid-19 vaccination (“Notice“) based on employees who experience injuries, illness or death as a result of the Covid-19 vaccine in the circumstances where the requirement to have the vaccine is an inherent requirement of the employee’s job or where the employee is required to do so in terms of his/her employer’s risk assessment.
Read our article discussing vaccination policies for the workplace for more on the implementation of a mandatory vaccination policy and the required risk assessment).
The Notice provides that if an employee is required to receive a Covid-19 vaccine, either as a result of an occupational health and safety risk assessment conducted by an employer or where the vaccine is an inherent requirement of employment, any injury, illness or death incurred as a result will be covered by the Compensation Fund.
However, in order for such cover to extend to an employee, there are 6 requirements that apply:
- The vaccine must be regarded as an inherent requirement of employment in terms of the employer’s risk assessment;
- The employee must have received a SAHPRA-approved Covid-19 vaccine;
- Evidence of the employer’s risk assessment and vaccination plan in terms of the Consolidated Directions on Occupational Health and Safety Measures in Certain Workplaces must be provided;
- The chronological sequence between the vaccine inoculation and the development of the employee’s symptoms and clinical signs must be provided;
- The employee must have presented with symptoms and clinical signs that are generally recognised as side effects of the Covid-19 vaccine; and
- Additional tests may be required to assess the presence of abnormalities of any organ affected.
A copy of the Notice can be accessed here.
Latest News
“Corporate Death by Winding-Up”: Pretoria High Court Reaffirms the Badenhorst Principle
by Eric Levenstein, Director and Head Insolvency & Business Rescue, Amy Mackechnie, Senior Associate and Clio Patricios, Candidate Attorney A [...]
South Africa’s Information Regulator: What the 2025/26 Annual Performance Plan means for Business (as presented to the Portfolio Committee on 5 May 2026
by Ahmore Burger-Smidt, Director and Head of Regulatory “It is only the inner sanctum of a person, such as his/her [...]
Urgency misconceived: A cautionary note on process, principle and professional responsibility
by Bradley Workman-Davies, Director The decision in Wheatley v Commission for Conciliation, Mediation & Arbitration & others (2026) 47 ILJ [...]
Digital taxes are reshaping cross-border e-commerce economics in Africa
by Tebogo Sibidla, Director Digital taxation has moved from policy debate to regulatory reality. Governments across the world are implementing [...]
A safe voice or silent risk: An attempt at reforming whistleblower protection through the Protected Disclosures Draft Bill
by Harold Jacobs, Director, Luyanda Lebepe, Senior Associate and Kian Steytler, Candidate Attorney The case of Babita Deokaran, a senior [...]
Recent Competition Tribunal Case clarifies approach to ownership conditions in South African merger approvals
by Pieter Steyn, Director In a recent case, the Competition Tribunal clarified its approach regarding the imposition of conditions for [...]
